1. Medtech Insight

PCORI Draft Research Agenda Offers Only Broad Areas Of Study

The Patient-Centered Outcomes Research Institute issues its draft national priorities and research agenda for comment Jan. 23. Rather than specific research items, the list contains five broad areas designed to elicit the greatest amount of input from stakeholders on what projects should be funded.

Those expecting to see a list of specific research items on the Patient-Centered Outcomes Research Institute’s draft of its initial national priorities and research agenda were probably disappointed last week when it was revealed that the agenda includes only broad, overarching topics.

But the reason for not narrowing the list to specifics was to allow for the greatest amount of input as...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight

J&J Bets On Robotics, Cardiovascular To Grow Medtech As Tariff Hit Eases, US Manufacturing Grows

 
• By Shubham Singh

Worldwide medtech sales totaled $8.5bn in Q2, up 6.1%. Sales grew 8% in the US and 4.1% outside the US. Cardiovascular, surgery and vision were the primary growth drivers. Acquisitions and divestitures had net positive impact of 200 basis points, largely due to the acquisition of Shockwave Medical.

Experts Call For Database Of Medical Device Labels

 
• By Elizabeth Orr

A recent JAMA column called for the US FDA to create an online database of medical device labeling, arguing that the move would increase transparency and help researchers, among other benefits. Medtech Insight discussed the idea with the paper’s lead author.

Execs On The Move: July 7–11, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.